Evidence map›Paper›PMID 28341845›Full record

ArticleScientific reports2017

The trimer interface in the quaternary structure of the bifunctional prokaryotic FAD synthetase from Corynebacterium ammoniagenes.

Ana Serrano, María Sebastián, Sonia Arilla-Luna, Silvia Baquedano, Beatriz Herguedas, Adrián Velázquez-Campoy, Marta Martínez-Júlvez, Milagros Medina

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Ana SerranoDepartamento de Bioquímica y Biología Molecular y Celular, Facultad de Ciencias, and Institute of Biocomputation and Physics of Complex Systems (Joint Units BIFI-IQFR and CBsC-CSIC), Universidad de Zaragoza, Zaragoza, Spain.
María SebastiánDepartamento de Bioquímica y Biología Molecular y Celular, Facultad de Ciencias, and Institute of Biocomputation and Physics of Complex Systems (Joint Units BIFI-IQFR and CBsC-CSIC), Universidad de Zaragoza, Zaragoza, Spain.
Sonia Arilla-LunaDepartamento de Bioquímica y Biología Molecular y Celular, Facultad de Ciencias, and Institute of Biocomputation and Physics of Complex Systems (Joint Units BIFI-IQFR and CBsC-CSIC), Universidad de Zaragoza, Zaragoza, Spain.
Silvia BaquedanoDepartamento de Bioquímica y Biología Molecular y Celular, Facultad de Ciencias, and Institute of Biocomputation and Physics of Complex Systems (Joint Units BIFI-IQFR and CBsC-CSIC), Universidad de Zaragoza, Zaragoza, Spain.
Beatriz HerguedasDepartamento de Bioquímica y Biología Molecular y Celular, Facultad de Ciencias, and Institute of Biocomputation and Physics of Complex Systems (Joint Units BIFI-IQFR and CBsC-CSIC), Universidad de Zaragoza, Zaragoza, Spain.
Adrián Velázquez-CampoyDepartamento de Bioquímica y Biología Molecular y Celular, Facultad de Ciencias, and Institute of Biocomputation and Physics of Complex Systems (Joint Units BIFI-IQFR and CBsC-CSIC), Universidad de Zaragoza, Zaragoza, Spain.
Marta Martínez-JúlvezDepartamento de Bioquímica y Biología Molecular y Celular, Facultad de Ciencias, and Institute of Biocomputation and Physics of Complex Systems (Joint Units BIFI-IQFR and CBsC-CSIC), Universidad de Zaragoza, Zaragoza, Spain.ORCID 0000-0001-9047-0046
Milagros MedinaDepartamento de Bioquímica y Biología Molecular y Celular, Facultad de Ciencias, and Institute of Biocomputation and Physics of Complex Systems (Joint Units BIFI-IQFR and CBsC-CSIC), Universidad de Zaragoza, Zaragoza, Spain. mmedina@unizar.es.ORCID 0000-0001-8743-0182
Universidad de Zaragoza · ESMRC Laboratory of Molecular Biology · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bifunctional FAD synthetases (FADSs) fold in two independent modules; The C-terminal riboflavin kinase (RFK) catalyzes the RFK activity, while the N-terminal FMN-adenylyltransferase (FMNAT) exhibits the FMNAT activity. The search for macromolecular interfaces in the Corynebacterium ammoniagenes FADS (CaFADS) crystal structure predicts a dimer of trimers organization. Within each trimer, a head-to-tail arrangement causes the RFK and FMNAT catalytic sites of the two neighboring protomers to approach, in agreement with active site residues of one module influencing the activity at the other. We analyze the relevance of the CaFADS head-to-tail macromolecular interfaces to stabilization of assemblies, catalysis and ligand binding. With this aim, we evaluate the effect of point mutations in loop L1c-FlapI, loop L6c, and helix α1c of the RFK module (positions K202, E203, F206, D298, V300, E301 and L304), regions at the macromolecular interface between two protomers within the trimer. Although none of the studied residues is critical in the formation and dissociation of assemblies, residues at L1c-FlapI and helix α1c particularly modulate quaternary architecture, as well as ligand binding and kinetic parameters involved with RFK and FMNAT activities. These data support the influence of transient oligomeric structures on substrate accommodation and catalysis at both CaFADS active sites.

Indexed as

Protein Structure, QuaternaryAdenosine TriphosphateBacterial ProteinsCatalytic DomainCorynebacteriumFlavinsNucleotidyltransferasesPhosphotransferases (Alcohol Group Acceptor)Adenosine TriphosphateBacterial ProteinsFlavinsFMN adenylyltransferaseNucleotidyltransferasesPhosphotransferases (Alcohol Group Acceptor)riboflavin kinase

Identifiers

PMID28341845
PMCPMC5428420
OpenAlexW2598332119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.